VIOT:NASDAQViomi Technology Co., Ltd Analysis
Data as of 2026-07-31 - not real-time
$0.76
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Technical indicators signal continued weakness: the short‑term moving average sits below the longer‑term average, the 14‑day RSI is in the lower half of its range, and the MACD line trails its signal, all pointing to bearish momentum. Volume is on a downtrend and price is flirting with a key support level, while the broader market sentiment is in an "Extreme Greed" phase that may mask underlying fragility. Adding to the pressure, Nasdaq has formally warned the company for maintaining a bid price below the required minimum for thirty consecutive days, and recent commentary notes a slowdown in Chinese durable‑goods demand, directly impacting Viomi's core water‑system business.
Valuation appears dramatically cheap relative to a disclosed discounted cash‑flow estimate that suggests a fair value many times the current price, and the stock trades at a very low price‑to‑earnings and price‑to‑book multiple. However, the balance sheet tells a cautionary tale: free cash flow is negative, debt‑to‑equity is high, and operating margins are razor‑thin. The combination of elevated systematic risk (beta above market), high 30‑day volatility, and liquidity constraints (low and falling trading volume) makes the upside speculative, though a long‑run turnaround could unlock substantial value.
Valuation appears dramatically cheap relative to a disclosed discounted cash‑flow estimate that suggests a fair value many times the current price, and the stock trades at a very low price‑to‑earnings and price‑to‑book multiple. However, the balance sheet tells a cautionary tale: free cash flow is negative, debt‑to‑equity is high, and operating margins are razor‑thin. The combination of elevated systematic risk (beta above market), high 30‑day volatility, and liquidity constraints (low and falling trading volume) makes the upside speculative, though a long‑run turnaround could unlock substantial value.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish technical setup with SMA crossover and MACD divergence
- Nasdaq bid‑price deficiency warning
- Decreasing volume and proximity to support
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Valuation gap versus DCF fair value
- Persistent negative free cash flow
- High debt load relative to equity
Long Term
> 3 yearsPositive
Model confidence: 6/10
Key Factors
- Potential for a multi‑fold price appreciation if turnaround succeeds
- Extremely low PE and PB multiples
- Opportunity to benefit from any future subsidy or policy support for home water solutions
Key Metrics & Analysis
Financial Health
Revenue Growth-25.90%
Profit Margin5.83%
P/E Ratio2.6
ROE9.52%
ROA3.23%
Debt/Equity7.73
P/B Ratio0.2
Op. Cash Flow$154.6M
Free Cash Flow$-41991752
Technical Analysis
TrendBearish
RSI38.5
Support$0.75
Resistance$0.93
MA 20$0.79
MA 50$0.86
MA 200$1.52
MACDBearish
VolumeDecreasing
Fear & Greed Index91.52
Valuation
Fair Value$35.92
Target Price$2.25
Upside/Downside197.78%
GradeUndervalued
TypeValue
Risk Assessment
Beta1.20
Volatility43.85%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.